| Home | E-Submission | Sitemap | Editorial Office |  
Korean J Urol Oncol > Volume 14(1); 2016 > Article
The Korean Journal of Urological Oncology 2016;14(1): 10-17.
남성호르몬 박탈요법을 받은 전립선암 환자의 삶의 질
신보성, 강택원
전남대학교 의과대학 비뇨기과학교실
Quality of Life in Prostate Cancer Patient Undergoing Androgen Deprivation Therapy
Bosung Shin , Taek Won Kang
Department of Urology, Chonnam National University Medical School, Gwangju, Korea
Published online: April 30, 2016.
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Androgen deprivation therapy(ADT) has been one of the standard protocol for treating prostate cancer. The role for hormonal treatment initially was restricted to men with metastatic and inoperable, locally advanced disease. Now it has been extended to neoadjuvant or adjuvant therapy for surgery and radiotherapy, for biochemical relapse after surgery or radiation, and even as primary therapy for non-metastatic disease. Although ADT can improve survival, it can also cause significant morbidity and a decrement in quality of life(QOL). In this article, we discuss QOL problem caused by ADT and suggest for mitigating harm of ADT. (Korean J Urol Oncol 2016;14:10-17)
Key Words: Prostate Neoplasms; Gonadotropin-releasing hormone; Quality of life
Editorial Office
Department of Urology, Chung-Ang University Hospital
102 Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-1819   Fax: +82-2-6294-1406   E-mail: journal@kjuo.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Urological Oncology Society and The Korean Prostate Society.                 Developed in M2PI
Close layer
prev next